PMID
Data
Article Title
Organization
Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity.

Beijing Institute of Technology
Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.

Fudan University
Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design.

Cubist Pharmaceuticals
Discovery of KDM5A inhibitors: Homology modeling, virtual screening and structure-activity relationship analysis.

Sichuan University
Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.

Beijing Pearl Biotech
Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB.

Cubist Pharmaceuticals
Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors.

Cubist Pharmaceuticals
Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO).

Zhengzhou University
Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.

Beijing Pearl Biotech
Polyketides witha-Glucosidase Inhibitory Activity from a Mangrove Endophytic Fungus, Penicillium sp. HN29-3B1.

Hebei University
Synthesis and biological evaluation of pyridinone analogues as novel potent HIV-1 NNRTIs.

Peking University
Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I).

China Pharmaceutical University
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.

Fudan University
Synthesis and enzymatic evaluation of phosphoramidon and itsß anomer: Anomerization ofa-l-rhamnose triacetate upon phosphitylation.

Jiangxi Science and Technology Normal University
Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides.

TBA
Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1.

TBA
Studies on gambogic acid (IV): Exploring structure-activity relationship with I¿B kinase-beta (IKKß).

China Pharmaceutical University
Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors.

Fudan University
Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitors.

Lexicon Pharmaceuticals
Molecular hybridization, synthesis, and biological evaluation of novel chroman I(Kr) and I(Ks) dual blockers.

China Pharmaceutical University
Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disorders.

Lexicon Pharmaceuticals
Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones.

Harvard Medical School
Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein.

The Scripps Research Institute
A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19.

Pfizer
Design, synthesis and bioactivity evaluation of novel fusion peptides and their CPT conjugates inducing effective anti-tumor responses on HER2 positive tumors.

China Pharmaceutical University
Discovery of a Novel Thienopyrimidine Compound as a Urate Transporter 1 and Glucose Transporter 9 Dual Inhibitor with Improved Efficacy and Favorable Druggability.

Shandong University
Exploration and Biological Evaluation of 1,3-Diamino-7

Chinese Academy of Medical Sciences&Peking Union Medical College
Targeting VPS34 in autophagy: An update on pharmacological small-molecule compounds.

Southwest Jiaotong University
Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss.

Pfizer
Discovery of aromatic 2-(3-(methylcarbamoyl) guanidino)-N-aylacetamides as highly potent chitinase inhibitors.

China Agricultural University
Design, synthesis, and structure-activity relationship of novel RIPK2 inhibitors.

Soochow University
Design of novel Xenopus GLP-1-based dual glucagon-like peptide 1 (GLP-1)/glucagon receptor agonists.

Affiliated Tumor Hospital of Guangxi Medical University
Peptide-based long-acting co-agonists of GLP-1 and cholecystokinin 1 receptors as novel anti-diabesity agents.

Jiangsu Normal University
Optimization of Beclin 1-Targeting Stapled Peptides by Staple Scanning Leads to Enhanced Antiproliferative Potency in Cancer Cells.

Fudan University
Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity.

Soochow University
Design, synthesis, and biological evaluation of novel sulindac derivatives as partial agonists of PPARγ with potential anti-diabetic efficacy.

Xiamen University
Rational design and biological evaluation of gemfibrozil modified Xenopus GLP-1 derivatives as long-acting hypoglycemic agents.

Jiangnan University
Stapled and

Jiangsu Normal University
Soluble guanylate cyclase stimulators for the treatment of hypertension: Discovery of MK-2947.

Merck
Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase.

Tongji University
2-(4-Fluorophenyl)-quinazolin-4(3H)-one as a novel tyrosinase inhibitor: Synthesis, inhibitory activity, and mechanism.

Jiangxi Normal University
Design, synthesis and biological evaluation of tetrazole-containing RXRα ligands as anticancer agents.

Xiamen University
Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase.

Yunnan University
Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives.

Fudan University
A Series of Compounds Bearing a Dipyrido-Pyrimidine Scaffold Acting as Novel Human and Insect Pest Chitinase Inhibitors.

Dalian University of Technology
-Benzyl/Aryl Substituted Tryptanthrin as Dual Inhibitors of Indoleamine 2,3-Dioxygenase and Tryptophan 2,3-Dioxygenase.

Fudan University
5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists.

Ligand Pharmaceuticals
Modification of the Thioglycosyl-Naphthalimides as Potent and Selective Human O-GlcNAcase Inhibitors.

China Agricultural University
Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.

Universities of Shandong
Discovery of Selective M4 Muscarinic Acetylcholine Receptor Agonists with Novel Carbamate Isosteres.

Pfizer
Design of Specific Serine Protease Inhibitors Based on a Versatile Peptide Scaffold: Conversion of a Urokinase Inhibitor to a Plasma Kallikrein Inhibitor.

Aarhus University
Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B Inhibitors.

Cubist Pharmaceuticals
Design and bio-evaluation of indole derivatives as potent Kv1.5 inhibitors.

China Pharmaceutical University
Development of Unsymmetrical Dyads As Potent Noncarbohydrate-Based Inhibitors against Human β-N-Acetyl-d-hexosaminidase.

East China University of Science and Technology
Design, synthesis, and evaluation of metabolism-based analogues of haloperidol incapable of forming MPP+-like species.

Florida A and M University
Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells.

Nantong University
Selective inhibition of β-N-acetylhexosaminidases by thioglycosyl-naphthalimide hybrid molecules.

Dalian University of Technology
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans.

Novartis Institutes For Biomedical Research
BCL-2 Inhibitors

Eil Therapeutics
AROMATIC VINYL COMPOUND, METAL COMPLEX THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Shanghai Maxinovel Pharmaceuticals Co.
MEDICAL USE OF N4-HYDROXY CITICOLINE COMPOUNDS

Immunic
Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof

Syntara
MACROCYCLIC COMPOUND

Asahi Kasei Pharma
PYRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF

Sichuan Kelun-Biotech Biopharmaceutical
Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (USP1) inhibitors

Ksq Therapeutics
4H-pyrrolo[3,2-c]pyridin-4-one derivatives

Bayer Aktiengesellschaft
Quinoline compounds as modulators of RAGE activity and uses thereof

TBA
Androgen receptor modulating compounds

Orion
2,4-disubstituted 7H-pyrrolo[2,3-d]pyrimidine derivative, preparation method and medicinal use thereof

Shanghai Haiyan Pharmaceutical Technology
Matrix metalloproteinase inhibitors and methods for the treatment of pain and other diseases

TBA
Synthesis and biological evaluation in vitro of selective, high affinity peptide antagonists of human melanin-concentrating hormone action at human melanin-concentrating hormone receptor 1.

Merck Research Laboratories
Biexponential kinetics of (R)-alpha-[3H]methylhistamine binding to the rat brain H3 histamine receptor.

Schering-Plough Research Institute